Cargando…
Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson’s disease
Glucose metabolism is dysregulated in Parkinson’s disease (PD) causing a shift toward the metabolism of lipids. Carnitine palmitoyl-transferase 1A (CPT1A) regulates the key step in the metabolism of long-chain fatty acids. The aim of this study is to evaluate the effect of downregulating CPT1, eithe...
Autores principales: | Trabjerg, Michael Sloth, Andersen, Dennis Christian, Huntjens, Pam, Mørk, Kasper, Warming, Nikolaj, Kullab, Ulla Bismark, Skjønnemand, Marie-Louise Nibelius, Oklinski, Michal Krystian, Oklinski, Kirsten Egelund, Bolther, Luise, Kroese, Lona J., Pritchard, Colin E. J., Huijbers, Ivo J., Corthals, Angelique, Søndergaard, Mads Toft, Kjeldal, Henrik Bech, Pedersen, Cecilie Fjord Morre, Nieland, John Dirk Vestergaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867753/ https://www.ncbi.nlm.nih.gov/pubmed/36681683 http://dx.doi.org/10.1038/s41531-023-00450-y |
Ejemplares similares
-
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS
por: Trabjerg, Michael Sloth, et al.
Publicado: (2021) -
Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models
por: Trabjerg, Michael Sloth, et al.
Publicado: (2020) -
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis
por: Mørkholt, Anne Skøttrup, et al.
Publicado: (2019) -
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents
por: Mørkholt, Anne Skøttrup, et al.
Publicado: (2020) -
Aquaporins in the Spinal Cord
por: Oklinski, Michal K., et al.
Publicado: (2016)